Does SINTILIMAB Cause Immune-mediated enterocolitis? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Immune-mediated enterocolitis have been filed in association with SINTILIMAB. This represents 1.1% of all adverse event reports for SINTILIMAB.
7
Reports of Immune-mediated enterocolitis with SINTILIMAB
1.1%
of all SINTILIMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Immune-mediated enterocolitis From SINTILIMAB?
Of the 7 reports, 4 (57.1%) required hospitalization, and 2 (28.6%) were considered life-threatening.
Is Immune-mediated enterocolitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SINTILIMAB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does SINTILIMAB Cause?
Myelosuppression (127)
Nausea (77)
Rash (72)
Vomiting (68)
Off label use (64)
Hypothyroidism (62)
Diarrhoea (61)
Fatigue (60)
Anaemia (59)
Pyrexia (51)
What Other Drugs Cause Immune-mediated enterocolitis?
NIVOLUMAB (1,289)
IPILIMUMAB (988)
PEMBROLIZUMAB (858)
CARBOPLATIN (307)
PACLITAXEL (188)
DURVALUMAB (165)
ATEZOLIZUMAB (156)
LENVATINIB (143)
PEMETREXED (129)
BEVACIZUMAB (92)
Which SINTILIMAB Alternatives Have Lower Immune-mediated enterocolitis Risk?
SINTILIMAB vs SIPONIMOD
SINTILIMAB vs SIPULEUCEL-T
SINTILIMAB vs SIROLIMUS
SINTILIMAB vs SIRUKUMAB
SINTILIMAB vs SITAGLIPTIN